Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.00 USD
Change Today -0.20 / -1.96%
Volume 255.7K
As of 5:10 PM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

ovascience inc (OVAS) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/25/15 - $55.69
52 Week Low
09/30/15 - $7.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OVASCIENCE INC (OVAS)

Related News

No related news articles were found.

ovascience inc (OVAS) Related Businessweek News

No Related Businessweek News Found

ovascience inc (OVAS) Details

OvaScience, Inc., a life science company, engages in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It is developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize in vitro fertilization (IVF) comprising AUGMENT to improve the energy and health of the woman’s eggs by using mitochondria from a woman's EggPC cells; OvaPrime treatment for boosting a woman's egg reserve by transferring the EggPCs from woman's own ovaries; OvaTure to create mature fertilizable eggs from a woman’s own EggPC cells without the need for hormone injections; and OvaXon for the prevention of genetic disease and animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is based in Cambridge, Massachusetts.

52 Employees
Last Reported Date: 03/16/15
Founded in 2011

ovascience inc (OVAS) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: --
President and Chief Scientific Officer
Total Annual Compensation: $644.0K
Compensation as of Fiscal Year 2014.

ovascience inc (OVAS) Key Developments

OvaScience, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015

OvaScience, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2015. Net loss for the three months ended September 30, 2015 was $17.9 million, or $0.66 per basic and diluted share, as compared to net loss of $12.9 million, or $0.54 per basic and diluted share, for the three months ended September 30, 2014. The increase in net loss is primarily attributable to planned higher personnel costs, stock-based compensation, and costs associated with the launch of the AUGMENT treatment in certain international IVF clinics. For the quarter, the company reported revenue of $0.075 million. Loss from operations was of $17.772 million compared to $12.399 million a year ago. For nine months, the company reported revenue of $0.120 against $0.00 a year ago. Loss from operations was of $51.759 million compared to $29.644 million a year ago. Net loss was $52.618 million or $1.95 per basic and diluted share compared to $30.630 million or $1.38 per basic and diluted share a year ago.

OvaScience, Inc. - Special Call

To provide an update on corporate goal for AUGMENT Treatment

OvaScience, Inc. Presents at Boston Biotech Conferences 2015, Nov-11-2015

OvaScience, Inc. Presents at Boston Biotech Conferences 2015, Nov-11-2015. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States. Presentation Date & Speakers: Nov-11-2015, Theresa McNeely, Chief Communications Officer and Executive Vice President. Nov-12-2015, Arthur Tzianabos, President and Chief Scientific Officer.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVAS:US $10.00 USD -0.20

OVAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OVAS.
View Industry Companies

Industry Analysis


Industry Average

Valuation OVAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2,272.3x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,092.6x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OVASCIENCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at